These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Marrannes R; Willems R; De Prins E; Wauquier A Brain Res; 1988 Aug; 457(2):226-40. PubMed ID: 2851364 [TBL] [Abstract][Full Text] [Related]
8. The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics. Daniell LC Pharmacol Biochem Behav; 1990 May; 36(1):111-5. PubMed ID: 2190239 [TBL] [Abstract][Full Text] [Related]
12. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Stasheff SF; Anderson WW; Clark S; Wilson WA Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762 [TBL] [Abstract][Full Text] [Related]
14. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096 [TBL] [Abstract][Full Text] [Related]
15. Release of [3H]norepinephrine from rat hippocampal slices by N-methyl-D-aspartate: comparison of the inhibitory effects of Mg2+ and MK-801. Schmidt CJ; Taylor VL Eur J Pharmacol; 1988 Oct; 156(1):111-20. PubMed ID: 2850205 [TBL] [Abstract][Full Text] [Related]
16. NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants. Bertram EH; Lothman EW Epilepsy Res; 1990 Apr; 5(3):177-84. PubMed ID: 2166658 [TBL] [Abstract][Full Text] [Related]
17. Effect of anticonvulsant treatment on kainic acid-induced increases in peptide levels. Marksteiner J; Prommegger R; Sperk G Eur J Pharmacol; 1990 Jun; 181(3):241-6. PubMed ID: 1974515 [TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Ormandy GC; Jope RS; Snead OC Exp Neurol; 1989 Nov; 106(2):172-80. PubMed ID: 2553470 [TBL] [Abstract][Full Text] [Related]
19. Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain. Foster AC; Gill R; Kemp JA; Woodruff GN Neurosci Lett; 1987 May; 76(3):307-11. PubMed ID: 3295603 [TBL] [Abstract][Full Text] [Related]
20. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Herberg LJ; Rose IC Psychopharmacology (Berl); 1989; 99(1):87-90. PubMed ID: 2550989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]